A quantitative approach to study indirect effects among disease proteins in the human protein interaction network
Open Access
- 29 July 2010
- journal article
- Published by Springer Nature in BMC Systems Biology
- Vol. 4 (1) , 103
Abstract
Systems biology makes it possible to study larger and more intricate systems than before, so it is now possible to look at the molecular basis of several diseases in parallel. Analyzing the interaction network of proteins in the cell can be the key to understand how complex processes lead to diseases. Novel tools in network analysis provide the possibility to quantify the key interacting proteins in large networks as well as proteins that connect them. Here we suggest a new method to study the relationships between topology and functionality of the protein-protein interaction network, by identifying key mediator proteins possibly maintaining indirect relationships among proteins causing various diseases.Keywords
This publication has 39 references indexed in Scilit:
- Identifying disease-specific genes based on their topological significance in protein networksBMC Systems Biology, 2009
- Shared and Distinct Genetic Variants in Type 1 Diabetes and Celiac DiseaseNew England Journal of Medicine, 2008
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- A computational analysis of protein-protein interaction networks in neurodegenerative diseasesBMC Systems Biology, 2008
- Protein networks in diseaseGenome Research, 2008
- The human disease networkProceedings of the National Academy of Sciences, 2007
- The Importance of Bottlenecks in Protein Networks: Correlation with Gene Essentiality and Expression DynamicsPLOS Computational Biology, 2007
- A network perspective on the topological importance of enzymes and their phylogenetic conservationBMC Bioinformatics, 2007
- Discovering disease-genes by topological features in human protein–protein interaction networkBioinformatics, 2006
- β2-Adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmaticsHuman Genetics, 2006